You have 9 free searches left this month | to do more

jnj-67571244

Jnj 67571244 is a drug used to treat Leukemia, Myeloid, Acute and Myelodysplastic Syndromes. Jnj 67571244 is being actively studied in 1 study; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCBarbara Ann Karmanos Cancer Institute
Beth Israel Deaconess Medical Center
Clinica Univ. de Navarra
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • JNJ-67571244
  • Boston, Massachusetts
  • +16 more
2021-12-02
Dec 2, 2021